SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (512)6/13/1998 12:06:00 AM
From: drdan  Read Replies (2) of 5402
 
I'm back. Thought I might take a moment to sum up the key points from this extract- 1)the pfc product is compatible with mammalian red cells 2) the pfc compound with additional fluid to make up for any blood volume loss got oxygen to tissues as well as a person's own red cells 3) the issue of increased heart rate and cardiac output May or may not be of significance in humans with normal cardiac function. While this info is from a very small cohort of dogs, I feel that this is promising info. This is not a shlock product, regardless of what anyone says...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News